Melissa Frey—a gynecologic oncologist, cancer geneticist, and researcher—discusses the critical importance of early cancer risk assessment and Ambry’s Progeny program.

Combining annual breast density monitoring with a validated, evolving risk model like Tyrer-Cuzick offers the most accurate roadmap for personalized screening and early detection.

This installment of The Gene Scene covers the FBN1 gene (NM_000138.4). Pathogenic variants in this gene are known to cause Marfan syndrome and other conditions.

The Gene Scene covers TTN and related cardiomyopathy, muscular dystrophy, and other myopathies.

Maggie Ward, an APRN and board certified as an advanced genetics nurse and oncology certified nurse, explains the importance of RNA in her practice.

The Gene Scene covers RPS20